# Study to Evaluate Safety and Pharmacokinetics of UB-421 Antibody in HIV-1 Infected Adults

> **NCT01140126** · PHASE1 · COMPLETED · sponsor: **United Biomedical** · enrollment: 20 (actual)

## Conditions studied

- HIV-1 Infection in Adults (Asymptomatic)

## Interventions

- **DRUG:** Antibody UB-421

## Key facts

- **NCT ID:** NCT01140126
- **Lead sponsor:** United Biomedical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2011-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01140126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01140126, "Study to Evaluate Safety and Pharmacokinetics of UB-421 Antibody in HIV-1 Infected Adults". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01140126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*